Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.

Saved in:
Bibliographic Details
Title: Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.
Authors: Menke JR; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States., Aypar U; Division of Cytogenetics, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Bangs CD; Division of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States., Cook SL; Department of Laboratory Medicine, San Francisco Veterans Administration Health Care System, San Francisco, CA, United States., Gupta S; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.; Division of Hematopathology, Department of Laboratory Medicine, San Francisco, CA, United States., Hasserjian RP; Division of Hematopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States., Kong CS; Division of Cytopathology, Department of Pathology, Stanford University, Stanford, CA, United States., Lin O; Division of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Long SR; Division of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States., Ly A; Division of Cytopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States., Menke JAS; Senior Backend Engineer, Big Nerd Ranch, Atlanta, GA, United States., Natkunam Y; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States., Ruiz-Cordero R; Division of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Divisons of Molecular Genetic Pathology, Cytopathology, and Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, United States., Spiteri E; Division of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States., Ye J; Division of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States., Zadeh SL; Division of Cytopathology, Department of Pathology, University of Virginia, Charlottesville, VA, United States., Gratzinger DA; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2024 Jun 06; Vol. 14, pp. 1408238. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1408238